Adrenergic Neural Cells are a subset of neurons that release the neurotransmitter norepinephrine, also known as noradrenaline. These cells are part of the sympathetic nervous system, a branch of the autonomic nervous system responsible for the "fight or flight" response. Adrenergic neurons play a crucial role in regulating various physiological functions, including heart rate, blood pressure, and the mobilization of energy resources. The release of norepinephrine from adrenergic neural cells activates adrenergic receptors on target tissues, leading to physiological responses such as increased heart rate, bronchodilation, and heightened alertness. Adrenergic signaling is essential for the body's response to stress and emergencies. Dysregulation of adrenergic neural cells is implicated in several medical conditions, including hypertension, heart failure, and certain neurological disorders. Medications that target adrenergic receptors are commonly used to manage conditions like hypertension and cardiac arrhythmias. Researchers study adrenergic neural cells to gain insights into the mechanisms of sympathetic nervous system function and to develop therapeutic interventions for conditions related to autonomic dysfunction. Understanding adrenergic signaling pathways provides avenues for developing drugs that selectively modulate sympathetic activity for improved treatment outcomes.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States